+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023

  • ID: 4702383
  • Report
  • November 2018
  • Region: Global
  • 280 pages
  • Azoth Analytics
UP TO OFF
until Aug 30th 2021

FEATURED COMPANIES

  • Aerie Pharmaceuticals
  • Allergan
  • Novartis
  • Ocular Therapeutix
  • Pfizer
  • Teva Pharmaceuticals
  • MORE
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Glaucoma Treatment Market. The report analyzes the global glaucoma treatment market By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others) and By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Others). The report analyzes the global glaucoma treatment market By Region (North America, Europe, Asia Pacific and Rest of the World) and By Country (U.S., Canada, U.K, Germany, India, China, Japan and Brazil). The report assesses the glaucoma treatment market for the historical period of 2013-2017 and the forecast period of 2018-2023.

According to the research report “Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)”, global glaucoma treatment market is projected to display a robust growth represented by a CAGR of 4.81 % during 2018 – 2023.

The segment of Prostaglandin Analogs witnessed growth at a noteworthy rate over the past few years backed by increased prevalence of glaucoma, easy availability of dug along with rising number of hospitals and their respective pharmacies. Amongst the regions, North America accounts for the largest regional share in the global glaucoma treatment market in 2018. Key factors driving the robust growth rate of North America region include Well developed healthcare infrastructure, favorable regulatory reforms, rising prevalence of glaucoma in the region.

The report titled “Global Glaucoma Treatment Market: Analysis By Indication, By Drug Class, By Sales Channel, By Region, By Country (2018 Edition): Forecast to 2023 - By Indication (Open Angle, Closed Angle, Secondary, Congenital, Others), By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors)” has covered and analyzed the potential of Global Glaucoma Treatment Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global glaucoma treatment. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Glaucoma Treatment Market (Actual Period: 2013-2017, Forecast Period: 2018-2023
  • Global Glaucoma Treatment Market – Size, Growth, Forecast
  • By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others
  • By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
  • By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others
Regional Markets – North America, Europe, APAC, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Glaucoma Treatment Market – Size, Growth, Forecast
  • By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
  • By Drug Class (Prostaglandin Analogs, Beta Blockers, Alpha Agonist, Carbonic Anhydrase Inhibitors, Others)
  • By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others
Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil (Actual Period: 2013-2017, Forecast Period: 2018-2023)
  • Glaucoma Treatment Market – Size, Growth, Forecast
  • By Indication (Open Angle Glaucoma, Closed Angle Glaucoma, Secondary Glaucoma, Congenital Glaucoma, Others)
  • By Sales Channel – Hospital Pharmacy, Retail Pharmacy, Others
Other Report Highlights
  • Market Dynamics – Drivers and Restraints
  • Market Trends
  • Porter Five Force Analysis
  • Policy and Regulatory Landscape
  • Competitive Landscape
  • Company Analysis – Allergan, Pfizer, Novartis, Aerie Pharmaceuticals, Ocular Therapeutix, Teva Pharmaceuticals.
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aerie Pharmaceuticals
  • Allergan
  • Novartis
  • Ocular Therapeutix
  • Pfizer
  • Teva Pharmaceuticals
  • MORE
1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Glaucoma Treatment Market Overview

5. Global Glaucoma Treatment: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Global Glaucoma Treatment Market: Analysis By Indication
6.1 Global Glaucoma Treatment Market-By Indication: Breakdown(%)
6.1.1 Global Glaucoma Treatment Market Size and Share, By Indication, 2017
6.1.2 Global Glaucoma Treatment Market Size and Share, By Indication, 2023
6.2 Global Open Angle Glaucoma Treatment Market Overview
6.2.1 By Value (2013-2023)
6.3 Global Closed Angle Glaucoma Treatment Market Overview
6.3.1 By Value (2013-2023)
6.4 Global Secondary Glaucoma Treatment Market Overview
6.4.1 By Value (2013-2023)
6.5 Global Congenital Glaucoma Treatment Market Overview
6.5.1 By Value (2013-2023)
6.6 Global Others Glaucoma Treatment Market Overview
6.6.1 By Value (2013-2023)

7. Global Glaucoma Treatment Market: Analysis By Drug Class
7.1 Global Glaucoma Treatment Market: By Drug Class: Breakdown(%)
7.1.1 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class, 2017
7.1.2 Global Glaucoma Treatment Market Size and Share, Market-By Drug Class,2023
7.2 Global Prostaglandin Analogs Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
7.2 Global Beta Blockers Glaucoma Treatment Market Overview
7.2.1 By Value (2013-2023)
7.3 Global Alpha Agonist Glaucoma Treatment Market Overview
7.3.1 By Value (2013-2023)
7.4 Global Carbonic Anhydrase Inhibitors Glaucoma Treatment Market Overview
7.4.1 By Value (2013-2023)
7.5 Global Others Glaucoma Treatment Market Overview
7.5.1 By Value (2013-2023)

8. Global Glaucoma Treatment: Sales Channel Analysis
8.1 Global Glaucoma Treatment Market-By Sales Channel: Breakdown(%)
8.1.1 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2017
8.1.2 Global Glaucoma Treatment Market Size and Share, By Sales Channel, 2023
8.2 Global Hospital Pharmacy Glaucoma Treatment Market Overview
8.2.1 By Value (2013-2023)
8.3 Global Retail Pharmacy Glaucoma Treatment Market Overview
8.3.1 By Value (2013-2023)
8.4 Global Others Glaucoma Treatment Market Overview
8.4.1 By Value (2013-2023)

9. Global Glaucoma Treatment Market: Regional Analysis
9.1 Global Glaucoma Treatment Market, By Region: Breakdown (%)
9.1.1 Global Glaucoma Treatment Market Size, By Region, 2017 (%)
9.1.2 Global Glaucoma Treatment Market Size, By Region, 2023 (%)
9.2 North America Glaucoma Treatment Market: An Analysis
9.2.1 By Value (2013-2017)
9.2.2 By Value (2018-2023)

9.3 North America Glaucoma Treatment Market: Segment Analysis
9.3.1 North America Glaucoma Treatment Market: By Indication, By Value(2013-2023)
9.3.2 North America Glaucoma Treatment Market: By Drug Class, By value (2013-2023)
9.3.4 North America Glaucoma TreatmentMarket: By Sales Channel, By Value (2013-2023)
9.4 North America Glaucoma Treatment Market: Country Analysis (U.S. and Canada)
9.4.1 U.S. Glaucoma Treatment Market, By Value (2013-2023)
9.4.1.1 U.S. Glaucoma Treatment Market, By Indication, By Value (2013-2023
9.4.1.2 U.S. Glaucoma Treatment, By Sales Channel, By Value (2013-2023)
9.4.2 Canada Glaucoma Treatment Market, By Value (2013-2023)
9.4.2.1 Canada Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.4.2.2 Canada Glaucoma TreatmentMarket, By Sales Channel By Value (2013-2023)

9.5 Europe Glaucoma Treatment Market: An Analysis
9.5.1 By Value (2013-2017)
9.5.2 By Value (2018-2023)
9.6 Europe Glaucoma Treatment Market: Segment Analysis
9.6.1 Europe Glaucoma Treatment Market: By Indication
9.6.2 Europe Glaucoma Treatment Market: By Drug Class
9.6.3 Europe Glaucoma TreatmentMarket: By Sales channel
9.7 Europe Glaucoma Treatment Market: Country Analysis (Germany, U.K., Rest of Europe)
9.7.1 Germany Glaucoma Treatment Market, By Value (2013-2023)
9.7.1.1 Germany Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.7.1.2 Germany Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
9.7.2 United Kingdom Glaucoma Treatment Market, By Value (2013-2023)
9.7.2.1 United Kingdom Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.7.2.2 United Kingdom Glaucoma Treatment Market, By Sales Channel;, By Value(2013-2023)
9.7.4 Rest of Europe Glaucoma Treatment Market, By Value (2013-2023)

9.8 Asia Pacific Glaucoma Treatment Market: An Analysis
9.8.1 By Value (2013-2017)
9.8.2 By Value (2018-2023)
9.9 Asia Pacific Glaucoma Treatment Market: Segment Analysis
9.9.1 Asia Pacific Glaucoma Treatment Market: By Indication
9.9.2 Asia Pacific Glaucoma Treatment Market: By Drug Class
9.9.3 Asia Pacific Glaucoma TreatmentMarket: By Sales Channel

9.10 Asia Pacific Glaucoma Treatment Market: Country Analysis (India, China Japan & Rest of Asia Pacific)
9.10.1 China Glaucoma Treatment Market, By Value (2013-2023)
9.10.1.1 China Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.10.1.2 China Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
9.10.2 Japan Glaucoma Treatmentes Market, By Value (2013-2023)
9.10.2.1 Japan Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.10.2.3 Japan Glaucoma TreatmentMarket, By Sales Channel, By value(2013-2023)
9.10.3 India Glaucoma Treatment Market, By Value (2013-2023)
9.10.3.1 India Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.10.3.2 India Glaucoma Treatment Market, By Sales Channel, By Value (2013-2023)
9.10.4 Rest of Asia Pacific Glaucoma Treatment Market, By Value (2013-2023)

9.11 Rest of World Glaucoma Treatment Market: An Analysis
9.11.1 By Value (2013-2017)
9.11.2 By Value (2018-2023)
9.12 Rest of World Glaucoma Treatment Market: Segment Analysis
9.12.1 Rest of World Glaucoma Treatment Market: By Indication, By Value(2013-2023)
9.12.2 Rest of World Dental System and Parts Market: By Drug Class n, By Value(2013-2023)
9.12.3 Rest of World Glaucoma Treatment Market: By Sales Channel, By Value(2013-2023)
9.13 Rest of World Glaucoma Treatment Market: Country Analysis (Brazil & Others)
9.13.1 Brazil Glaucoma Treatment Market, By Value (2013-2023)
9.13.1.1 Brazil Glaucoma Treatment Market, By Indication, By Value (2013-2023)
9.13.1.2 Brazil Glaucoma Treatment Market: By Sales Channel, By Value(2013-2023)
9.13.3 Others Glaucoma Treatment Market, By Value (2013-2023)

10. Market Dynamics
10.1 Drivers
10.2 Challenges

11. Market Trends
12. Competitive Landscape

13. Policy and Regulatory Landscape

14. Porter’s Five Forces Analysis

15. SWOT Analysis

16. Company Profiles
16.1 Teva Pharmaceuticals
16.2 Ocular Therapeutix
16.3 Pfizer
16.4 Bausch Health
16.5 Novartis
16.6 Allergan Plc.
16.7 Aerie Pharmaceuticals
16.8 Akorn Inc.
Note: Product cover images may vary from those shown
  • Allergan
  • Pfizer
  • Novartis
  • Aerie Pharmaceuticals
  • Ocular Therapeutix
  • Teva Pharmaceuticals
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll